161 related articles for article (PubMed ID: 11114737)
21. Impact of IGF-I/IGF-IR circuit on the angiogenetic properties of Ewing's sarcoma cells.
Strammiello R; Benini S; Manara MC; Perdichizzi S; Serra M; Spisni E; Picci P; Scotlandi K
Horm Metab Res; 2003; 35(11-12):675-84. PubMed ID: 14710346
[TBL] [Abstract][Full Text] [Related]
22. The IGF-I receptor in cancer research.
Baserga R
Exp Cell Res; 1999 Nov; 253(1):1-6. PubMed ID: 10579905
[TBL] [Abstract][Full Text] [Related]
23. Growth factor receptors as therapeutic targets: strategies to inhibit the insulin-like growth factor I receptor.
Surmacz E
Oncogene; 2003 Sep; 22(42):6589-97. PubMed ID: 14528284
[TBL] [Abstract][Full Text] [Related]
24. Down-regulation of insulin receptor by antibodies against the type I insulin-like growth factor receptor: implications for anti-insulin-like growth factor therapy in breast cancer.
Sachdev D; Singh R; Fujita-Yamaguchi Y; Yee D
Cancer Res; 2006 Feb; 66(4):2391-402. PubMed ID: 16489046
[TBL] [Abstract][Full Text] [Related]
25. Mutant IGF-I receptors as dominant negatives for growth and transformation.
Burgaud JL; Resnicoff M; Baserga R
Biochem Biophys Res Commun; 1995 Sep; 214(2):475-81. PubMed ID: 7677754
[TBL] [Abstract][Full Text] [Related]
26. Solution structure of ectodomains of the insulin receptor family: the ectodomain of the type 1 insulin-like growth factor receptor displays asymmetry of ligand binding accompanied by limited conformational change.
Whitten AE; Smith BJ; Menting JG; Margetts MB; McKern NM; Lovrecz GO; Adams TE; Richards K; Bentley JD; Trewhella J; Ward CW; Lawrence MC
J Mol Biol; 2009 Dec; 394(5):878-92. PubMed ID: 19835884
[TBL] [Abstract][Full Text] [Related]
27. Characterization of a novel primary mammary tumor cell line reveals that cyclin D1 is regulated by the type I insulin-like growth factor receptor.
Jones RA; Campbell CI; Petrik JJ; Moorehead RA
Mol Cancer Res; 2008 May; 6(5):819-28. PubMed ID: 18505926
[TBL] [Abstract][Full Text] [Related]
28. Role of the IGF-I receptor in the regulation of cell-cell adhesion: implications in cancer development and progression.
Mauro L; Salerno M; Morelli C; Boterberg T; Bracke ME; Surmacz E
J Cell Physiol; 2003 Feb; 194(2):108-16. PubMed ID: 12494449
[TBL] [Abstract][Full Text] [Related]
29. Combination therapy enhances the inhibition of tumor growth with the fully human anti-type 1 insulin-like growth factor receptor monoclonal antibody CP-751,871.
Cohen BD; Baker DA; Soderstrom C; Tkalcevic G; Rossi AM; Miller PE; Tengowski MW; Wang F; Gualberto A; Beebe JS; Moyer JD
Clin Cancer Res; 2005 Mar; 11(5):2063-73. PubMed ID: 15756033
[TBL] [Abstract][Full Text] [Related]
30. Growth inhibition of insulin-like growth factor I receptor monoclonal antibody to human colorectal cancer cells.
Zhang Y; Zhang Y
Cancer Invest; 2008; 26(3):230-6. PubMed ID: 18317963
[TBL] [Abstract][Full Text] [Related]
31. Spatial distribution of growth hormone receptor, insulin-like growth factor-I receptor and apoptotic chondrocytes during growth plate development.
Cruickshank J; Grossman DI; Peng RK; Famula TR; Oberbauer AM
J Endocrinol; 2005 Mar; 184(3):543-53. PubMed ID: 15749813
[TBL] [Abstract][Full Text] [Related]
32. Autocrine/paracrine involvement of insulin-like growth factor-I and its receptor in chronic lymphocytic leukaemia.
Schillaci R; Galeano A; Becu-Villalobos D; Spinelli O; Sapia S; Bezares RF
Br J Haematol; 2005 Jul; 130(1):58-66. PubMed ID: 15982345
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of insulin-like growth factor I receptor tyrosine kinase by ethanol.
Rubin R; Harrison R; Chen XF; Corzitotto J; Hoek JB; Hallak H
Biochem Pharmacol; 2004 Nov; 68(10):2009-17. PubMed ID: 15476672
[TBL] [Abstract][Full Text] [Related]
34. Controlling IGF-receptor function: a possible strategy for tumor therapy.
Baserga R
Trends Biotechnol; 1996 May; 14(5):150-2. PubMed ID: 8645448
[TBL] [Abstract][Full Text] [Related]
35. IGF-I receptor signalling in transformation and differentiation.
Valentinis B; Baserga R
Mol Pathol; 2001 Jun; 54(3):133-7. PubMed ID: 11376123
[TBL] [Abstract][Full Text] [Related]
36. The role of insulin-like growth factor I and its receptor in cell growth, transformation, apoptosis, and chemoresistance in solid tumors.
Grothey A; Voigt W; Schöber C; Müller T; Dempke W; Schmoll HJ
J Cancer Res Clin Oncol; 1999; 125(3-4):166-73. PubMed ID: 10235470
[TBL] [Abstract][Full Text] [Related]
37. Roles of the insulin-like growth factor I receptor C-terminus in cellular radioresistance.
Yu D; Shibuya H; Miura M
Biochem Biophys Res Commun; 2003 Nov; 311(1):174-8. PubMed ID: 14575710
[TBL] [Abstract][Full Text] [Related]
38. Survival factors and apoptosis.
O'Connor R
Adv Biochem Eng Biotechnol; 1998; 62():137-66. PubMed ID: 9755644
[TBL] [Abstract][Full Text] [Related]
39. Structure and function of the insulin-like growth factor I receptor.
Sepp-Lorenzino L
Breast Cancer Res Treat; 1998 Feb; 47(3):235-53. PubMed ID: 9516079
[TBL] [Abstract][Full Text] [Related]
40. Differentiation and malignant transformation: two roads diverged in a wood.
Baserga R; Morrione A
J Cell Biochem; 1999; Suppl 32-33():68-75. PubMed ID: 10629105
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
